Journal of Biological Chemistry, 2014 · DOI: 10.1074/jbc.M114.588871 · Published: November 21, 2014
Spinal cord injuries often lead to permanent loss of function due to the limited regenerative capacity of the spinal cord. This study explores a potential cell-based therapy using induced neural stem cells (iNSCs). Researchers directly converted fibroblasts (skin cells) into iNSCs and transplanted them into rats with spinal cord injuries to observe if these cells could aid in functional recovery. The results showed that iNSCs can differentiate into various types of nerve cells, promote nerve fiber regeneration, and reduce inflammation, leading to improved motor function in the injured rats.
iNSCs offer a promising cell-based therapy for spinal cord injury by replacing damaged cells and promoting tissue regeneration.
Because iNSCs can be derived from a patient's own fibroblasts, this approach minimizes the risk of immune rejection.
The study contributes to the development of new strategies for neural repair and functional recovery after SCI.